Sustained Clinical Benefit and Tolerability of Methotrexate Monotherapy After Thiopurine Therapy in Patients With Crohn's Disease
Author:
Publisher
Elsevier BV
Subject
Gastroenterology,Hepatology
Reference31 articles.
1. The second European evidence-based consensus on the diagnosis and management of Crohn's disease: current management;Dignass;J Crohn's Colitis,2010
2. Guideline “Diagnosis and treatment of inflammatory bowel disease in adults”. I. Diagnosis and treatment;van Bodegraven;Ned Tijdschr Geneeskd,2010
3. Usefulness of co-treatment with immunomodulators in patients with inflammatory bowel disease treated with scheduled infliximab maintenance therapy;Sokol;Gut,2010
4. Effectiveness of concomitant immunosuppressive therapy in suppressing the formation of antibodies to infliximab in Crohn's disease;Vermeire;Gut,2007
5. Comparison between methotrexate and azathioprine in the treatment of chronic active Crohn's disease: a randomised, investigator-blind study;Ardizzone;Dig Liver Dis,2003
Cited by 36 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Systematic review: Methotrexate—A poorly understood and underused medication in inflammatory bowel disease;Alimentary Pharmacology & Therapeutics;2024-07-30
2. Effectiveness and Tolerability of Methotrexate Combined with Biologics in Patients with Crohn’s Disease: A Multicenter Observational Study;Digestive Diseases and Sciences;2024-01-13
3. Differences in the risk of clinical failure between thiopurine and methotrexate in bio-naïve patients with Crohn’s disease: a Korean nationwide population-based study;Therapeutic Advances in Gastroenterology;2024-01
4. Cardiovascular implications of inflammatory bowel disease: An updated review;World Journal of Cardiology;2023-11-26
5. Anti-tumor necrosis factor alpha versus corticosteroids: a threefold difference in the occurence of venous thromboembolism in Inflammatory Bowel Disease – a systematic review and meta-analysis;Journal of Crohn's and Colitis;2023-11-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3